Oligomenorrhea is an abnormal bleeding pattern where menstrual bleeding occurs at intervals of greater than 35 days, with fewer than 9 periods in a year. The period may be light in flow, short in duration or occur at irregular intervals.

Causes of oligomenorrhea range from chromosomal abnormalities to hypothalamic-pituitary conditions to hormonal imbalances. A common cause of oligomenorrhea is polycystic ovary syndrome (PCOS), a hormonal imbalance that results in menstrual irregularity.

Menarche

Menarche is the first menstrual bleed in a female that has reached reproductive age. The median age at menarche is "12-13 years old across well-nourished populations in developed countries".

Causes

Premature ovarian insufficiency

Premature ovarian insufficiency (POI), also known as primary ovarian insufficiency, is defined as "menopause before the age of 40" and presents as a "spectrum of declining ovarian function" resulting in reduced fertility due to a decrease in ovarian follicle number. While majority of cases of POI are idiopathic, chromosomal abnormalities that result in the damage or loss of the X chromosome (i.e. Turner Syndrome, FMR1 pre-mutation carriers) have been described to reduce ovarian functionality and lead to premature ovarian insufficiency. In those experiencing oligomenorrhea or menstrual irregularity, a diagnosis of POI can be confirmed with two elevated follicle-stimulating hormone levels (greater than 30-40 mIU/mL) at least 1 month apart. Typical physical characteristics of Turner Syndrome include a webbed neck, low hairline, short stature, broad chest, and congenital heart defects. Irregular or absent menstrual cycles can occur with this condition as a result of streak ovaries or gonadal dysgenesis. It has been found that in individuals with Turner Syndrome "oocyte apoptosis is markedly accelerated in the early stage of fetal life," leading to low ovarian reserve and menstrual abnormalities. Many of these individuals are often first diagnosed when evaluated for menstrual irregularities.

Polycystic Ovary Syndrome

People with polycystic ovary syndrome (PCOS) are also likely to have oligomenorrhea. Polycystic ovary syndrome (PCOS) is a hormone disorder that is characterized by hyperandrogenism, polycystic ovaries, and menstrual irregularity. While there is no universally recognized definition of PCOS, all diagnostic schema require presence of at least two of the defining characteristics. Clinical signs of hyperandrogenism can include hirsutism, acne, acanthosis, virilization (deepening of the voice, male-pattern balding), weight gain, and menstrual abnormalities. Menstrual irregularity and infertility are common clinical manifestations of PCOS where individuals may experience infrequent periods, absent periods, or heavy and unpredictable cycles. As a result of hormone imbalance and chronic anovluation, individuals with PCOS can develop endometrial hyperplasia which can in-turn increase the risk of endometrial cancer. Eating disorders are risk factors for FHA due to the disruption of the normal hypothalamic-pituitary-ovarisn axis. Although menstrual disorders are most strongly associated with anorexia nervosa, bulimia nervosa may also result in oligomenorrhea or amenorrhea. There is some controversy regarding the mechanism for the menstrual dysregulation, since amenorrhea may sometimes precede substantial weight loss in some anorexics. Endurance exercises such as running or swimming can affect the reproductive physiology of female athletes. Female runners, swimmers and ballet dancers either menstruate infrequently in comparison to non-athletic females of comparable age or exhibit amenorrhea. A more recent study shows that athletes competing in sports that emphasize thinness or a specific weight exhibit a higher rate of menstrual dysfunction than either athletes competing in sports with less focus on these or control subjects.

Other causes

Oligomenorrhea can be a result of other various causes including prolactinomas (adenomas of the anterior pituitary), thyrotoxicosis, hormonal changes in perimenopause, Prader–Willi syndrome, and Graves' disease, certain medications, and breastfeeding.

Diagnostic analysis

Laboratory analysis of an individual experiencing oligomenorrhea may be a necessary part of evaluation. If the individual is sexually active, regardless of contraception use, it is important to test for possible pregnancy.

Treatment for premature ovarian insufficiency should focus on minimizing complications from estrogen deficiency. Hormone therapy in premenopausal individuals will help to replace hormones normally produced by the ovaries. Estrogen replacement can work to prevent osteoporosis, cardiovascular disease, and menopausal symptoms. The use of combined hormonal birth control pills has been shown to help regulate menstrual cycles and decrease the risk of endometrial cancer.